GlassScriptPhysician profile
Candace C Williams
NPI 1578279543
$1,395.17
in general payments reported to CMS, 2019-2025
13 companies · $672 in 2025
The $672 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $679 · 2024: $44.43 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $800.51 | 2023-2025 | |
| Ars Pharmaceuticals Operations, INC. | $149.02 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $108.92 | 2023 | Pifeltro |
| Astrazeneca Pharmaceuticals LP | $74.57 | 2025 | Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.49 | 2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $43.44 | 2025 | Trintellix |
| Novo Nordisk INC | $43.16 | 2024-2025 | Wegovy |
| Hologic Sales and Service, LLC | $34.98 | 2025 | Aptima |
| Mayne Pharma Commercial LLC | $24.87 | 2025 | |
| Glaxosmithkline, LLC. | $23.36 | 2025 | Shingrix, Arexvy |
| Currax Pharmaceuticals LLC | $16.52 | 2025 | Contrave |
| Pfizer INC. | $15.65 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.